Lamonica Stewart
Last active: 3/27/2014


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells. Bolden A, Bernard L, Jones D, Akinyeke T, Stewart LV (2012) PPAR Res : 929052
    › Citation · 22448169 (PubMed) · PMC3289875 (PubMed Central)
  2. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism. Akinyeke TO, Stewart LV (2011) Cancer Biol Ther 11(12): 1046-58
    › Citation · 21525782 (PubMed) · PMC3142365 (PubMed Central)
  3. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells. Moss PE, Lyles BE, Stewart LV (2010) Exp Cell Res 316(20): 3478-88
    › Citation · 20932825 (PubMed) · PMC2977976 (PubMed Central)
  4. Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways. Lyles BE, Akinyeke TO, Moss PE, Stewart LV (2009) Cell Cycle 8(2): 268-77
    › Citation · 19164938 (PubMed)